# Verrica Pharmaceuticals 401(k) Plan
Source: https://planprovider.pro/companies/verrica-pharmaceuticals-401k-plan

> Verrica Pharmaceuticals&#39;s 401(k) plan: 102 participants, plan year 2024 financials, providers, and benchmarks from Form 5500.

Form 5500 filing data for plan year 2024.

## Plan Snapshot

- **Plan Sponsor:** Verrica Pharmaceuticals

- **Sponsor EIN:** 463137900

- **Sponsor Address:** 44 WEST GAY STREET, WEST CHESTER, PA, 19380

- **Plan Type:** 401(k)

- **Total Participants:** 102

- **Total Assets:** $5.8M

## Key Plan Design Features

- **Auto-Enrollment:** Yes

- **Auto-Escalation:** No

- **Allows Roth Contributions:** Yes

- **Participant Loans:** No

- **Participant-Directed Investments:** Yes

- **ERISA Section 404(c) Fiduciary Safe Harbor:** Yes

## Plan Financials by Year

| Year|Participants|Total Assets|Employer Contrib.|Employee Contrib.|

| 2024|102|$5.8M|$788,471|$1.5M|

| 2023|133|$3.9M|$426,389|$802,395|

| 2022|48|$2.1M|$270,321|$565,551|

## Service Providers (Schedule C)

Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).

| Provider Name|
Role|
Direct Compensation|
Indirect Compensation|
Total Fees|

| FISCHER CUNNANE & ASSOCIATES LTD|Auditor|—|—|$0|

### Verified Provider Profiles

Direct links to verified profiles of matched retirement plan providers on PlanProvider.Pro:

- [FISCHER CUNNANE & ASSOCIATES LTD](https://planprovider.pro/provider/fischer-cunnane-and-associates-ltd) — Auditor

## Plan Fees & Expenses

Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.

- **Total Service Provider Fees:** $0

### Historical Administrative Expenses

Breakdown of administrative expense categories reported on Form 5500 filings.

| Year|
Total Admin Expenses|
Investment Mgmt Fees|
Contract Admin Fees|
IQPA Audit Fees|
Professional Fees|

| 2024|$20,377|—|—|—|—|

| 2023|—|—|—|—|—|

| 2022|—|—|—|—|—|

## Similar Plans

- [Sigmapharm Laboratories, LLC](https://planprovider.pro/companies/sigmapharm-laboratories-llc-plan-001) — 85 participants

- [Mylan Pharmaceuticals INC.](https://planprovider.pro/companies/mylan-pharmaceuticals-inc-401k-plan) — 81 participants

- [Therakos, LLC](https://planprovider.pro/companies/therakos-llc-plan) — 79 participants

- [Optinose Us, INC.](https://planprovider.pro/companies/optinose-us-inc-401k-plan) — 130 participants

- [Immunocore LLC](https://planprovider.pro/companies/immunocore-llc-401k-plan) — 148 participants

- [Boiron, INC](https://planprovider.pro/companies/boiron-inc-plan-001) — 149 participants

[View full interactive plan profile on PlanProvider.Pro](https://planprovider.pro/companies/verrica-pharmaceuticals-401k-plan)

&copy; 2026 PlanProvider.Pro
